These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 21697709)

  • 21. Determinants of disability and quality of life in mild to moderate Parkinson disease.
    Muslimovic D; Post B; Speelman JD; Schmand B; de Haan RJ;
    Neurology; 2008 Jun; 70(23):2241-7. PubMed ID: 18519873
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Driving assessment in Parkinson's disease--a novel predictor of performance?
    Cordell R; Lee HC; Granger A; Vieira B; Lee AH
    Mov Disord; 2008 Jul; 23(9):1217-22. PubMed ID: 18528878
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship of the Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) to functional, emotional, and neuropsychological outcomes.
    O'Brien A; Gaudino-Goering E; Shawaryn M; Komaroff E; Moore NB; DeLuca J
    Arch Clin Neuropsychol; 2007 Nov; 22(8):933-48. PubMed ID: 17851031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropsychological deficits and functional impairment in bipolar depression, hypomania and euthymia.
    Malhi GS; Ivanovski B; Hadzi-Pavlovic D; Mitchell PB; Vieta E; Sachdev P
    Bipolar Disord; 2007; 9(1-2):114-25. PubMed ID: 17391355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Actual reality: a new approach to functional assessment in persons with multiple sclerosis.
    Goverover Y; O'Brien AR; Moore NB; DeLuca J
    Arch Phys Med Rehabil; 2010 Feb; 91(2):252-60. PubMed ID: 20159130
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing cognitive deficits in bipolar disorder: are self-reports valid?
    Burdick KE; Endick CJ; Goldberg JF
    Psychiatry Res; 2005 Jul; 136(1):43-50. PubMed ID: 16024090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neuropsychological evaluation in patients with Parkinson's disease].
    Rodríguez-Agudelo Y; Corona-Vázquez T; Velázquez-Cardoso J
    Rev Invest Clin; 1998; 50(3):197-201. PubMed ID: 9763883
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive performance in nondemented nonpsychotic Parkinson disease patients with or without a history of depression prior to the onset of motor symptoms.
    Klepac N; Hajnsek S; Trkulja V
    J Geriatr Psychiatry Neurol; 2010 Mar; 23(1):15-26. PubMed ID: 19996416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia.
    Vendette M; Gagnon JF; Décary A; Massicotte-Marquez J; Postuma RB; Doyon J; Panisset M; Montplaisir J
    Neurology; 2007 Nov; 69(19):1843-9. PubMed ID: 17984452
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impaired eye movements in post-concussion syndrome indicate suboptimal brain function beyond the influence of depression, malingering or intellectual ability.
    Heitger MH; Jones RD; Macleod AD; Snell DL; Frampton CM; Anderson TJ
    Brain; 2009 Oct; 132(Pt 10):2850-70. PubMed ID: 19617197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Executive function in sleep apnea: controlling for attentional capacity in assessing executive attention.
    Verstraeten E; Cluydts R; Pevernagie D; Hoffmann G
    Sleep; 2004 Jun; 27(4):685-93. PubMed ID: 15283003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Computerized method for arm movement assessment in Parkinson's disease and cerebellar syndrome patients].
    Dordević O; Popović MB; Kostić V
    Srp Arh Celok Lek; 2005; 133(1-2):14-20. PubMed ID: 16053170
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological function and driving ability in people with Parkinson's disease.
    Stolwyk RJ; Charlton JL; Triggs TJ; Iansek R; Bradshaw JL
    J Clin Exp Neuropsychol; 2006 Aug; 28(6):898-913. PubMed ID: 16822731
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Depression and Parkinson disease].
    Errea JM; Ara JR
    Rev Neurol; 1999 Apr 1-15; 28(7):694-8. PubMed ID: 10363296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attention and psychomotor functioning in bipolar depression.
    Burdick KE; Gunawardane N; Goldberg JF; Halperin JM; Garno JL; Malhotra AK
    Psychiatry Res; 2009 Apr; 166(2-3):192-200. PubMed ID: 19272656
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH; Schuck S; Dubois B; Lépine JP; Gallarda T; Olié JP; Goni S; Troy S
    Encephale; 2003; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone therapy in men with Parkinson disease: results of the TEST-PD Study.
    Okun MS; Fernandez HH; Rodriguez RL; Romrell J; Suelter M; Munson S; Louis ED; Mulligan T; Foster PS; Shenal BV; Armaghani SJ; Jacobson C; Wu S; Crucian G
    Arch Neurol; 2006 May; 63(5):729-35. PubMed ID: 16682542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attentional functioning in fibromyalgia, rheumatoid arthritis, and musculoskeletal pain patients.
    Dick B; Eccleston C; Crombez G
    Arthritis Rheum; 2002 Dec; 47(6):639-44. PubMed ID: 12522838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of cognitive impairment in general functioning in major depression.
    Baune BT; Miller R; McAfoose J; Johnson M; Quirk F; Mitchell D
    Psychiatry Res; 2010 Apr; 176(2-3):183-9. PubMed ID: 20138370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual object recognition and attention in Parkinson's disease patients with visual hallucinations.
    Meppelink AM; Koerts J; Borg M; Leenders KL; van Laar T
    Mov Disord; 2008 Oct; 23(13):1906-12. PubMed ID: 18709671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.